000 01513 a2200421 4500
005 20250517173704.0
264 0 _c20181112
008 201811s 0 0 eng d
022 _a1549-9642
024 7 _a10.1016/j.nano.2017.08.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarris, Michael A
245 0 0 _aAptamer micelles targeting fractalkine-expressing cancer cells in vitro and in vivo.
_h[electronic resource]
260 _bNanomedicine : nanotechnology, biology, and medicine
_c01 2018
300 _a85-96 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aAptamers, Nucleotide
_xadministration & dosage
650 0 4 _aChemokine CX3CL1
_xmetabolism
650 0 4 _aColonic Neoplasms
_xdrug therapy
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aDrug Delivery Systems
650 0 4 _aFibroblasts
_xdrug effects
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMice
650 0 4 _aMicelles
650 0 4 _aPolyethylene Glycols
_xchemistry
650 0 4 _aTumor Cells, Cultured
700 1 _aPearce, Timothy R
700 1 _aPengo, Thomas
700 1 _aKuang, Huihui
700 1 _aForster, Colleen
700 1 _aKokkoli, Efrosini
773 0 _tNanomedicine : nanotechnology, biology, and medicine
_gvol. 14
_gno. 1
_gp. 85-96
856 4 0 _uhttps://doi.org/10.1016/j.nano.2017.08.020
_zAvailable from publisher's website
999 _c27566792
_d27566792